» Authors » Katsuya Aoki

Katsuya Aoki

Explore the profile of Katsuya Aoki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 61
Citations 523
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Morizawa Y, Mieda K, Tachibana A, Tomizawa M, Onishi K, Hori S, et al.
Int J Urol . 2025 Mar; PMID: 40079335
Objective: A stepwise approach is recommended for the treatment of daytime urinary incontinence, with standard urotherapy as the first-line treatment, followed by pharmacological treatment when standard urotherapy is unsuccessful. This...
2.
Itami Y, Omori C, Yoshikawa M, Inoue T, Matsumura Y, Aoki K, et al.
Nihon Hinyokika Gakkai Zasshi . 2025 Jan; 115(1):1-10. PMID: 39828342
(Purpose) We performed a clinical retrospective study on the evaluation of pembrolizumab treatment results for advanced urothelial cancer in our hospital. (Materials and Methods) Twenty-seven patients diagnosed with advanced or...
3.
Morizawa Y, Aoki K, Fukui S, Tomizawa M, Shimizu T, Onishi K, et al.
Int J Urol . 2024 Jan; 31(5):507-511. PMID: 38205874
Objectives: Many congenital hydronephroses spontaneously resolve. This study evaluated a long-term follow-up of more than 4 years of patients with congenital hydronephrosis at a single center. Methods: In total, 215...
4.
Morizawa Y, Aoki K, Fukui S, Tomizawa M, Shimizu T, Onishi K, et al.
Int J Urol . 2023 Nov; 31(2):170-176. PMID: 37934938
Objectives: Cryptorchidism (CO) diagnosis by palpation is challenging. Patients with suspected CO are primarily referred to pediatric urologists by general pediatricians and urologists. Currently, surgical treatment for CO is recommended...
5.
Miyahara M, Osaki K, Aoki K
Cureus . 2022 Aug; 14(8):e27654. PMID: 35935111
Acute pyelonephritis is the leading cause of bacterial infection among children. It can be difficult to diagnose early in the disease course owing to non-specific symptoms and physical findings. Recently,...
6.
Miyake M, Nishimura N, Ohnishi S, Oda Y, Miyamoto T, Shimizu T, et al.
Support Care Cancer . 2022 Apr; 30(7):6145-6153. PMID: 35426045
Purpose: The level of 6-sulfatoxy-melatonin (SaMT), a metabolite of melatonin, in first-void morning urine reflects blood melatonin levels from the previous night. We investigated the association between urine SaMT and...
7.
Torimoto K, Ueda T, Kasahara M, Hirayama A, Matsushita C, Matsumoto Y, et al.
Low Urin Tract Symptoms . 2022 Mar; 14(5):334-340. PMID: 35307976
Objectives: Diagnosis of Hunner-type interstitial cystitis (HIC) relies on the ability to identify Hunner lesions endoscopically, which can lead to storage symptom misdiagnosis. Here, we examined serum biomarkers for HIC...
8.
Miyake M, Nishimura N, Shimizu T, Ohnishi M, Kuwada M, Itami Y, et al.
Cancer Manag Res . 2022 Feb; 14:623-635. PMID: 35210859
Purpose: The treatment landscape for advanced, unresectable, or metastatic urothelial carcinoma (aUC) has shifted substantially since the advent of immune checkpoint inhibitors (ICIs). We investigated the extent to which pembrolizumab...
9.
Miyake M, Shimizu T, Nishimura N, Kiba K, Maesaka F, Oda Y, et al.
Clin Genitourin Cancer . 2021 Dec; 20(2):196.e1-196.e9. PMID: 34916166
Introduction: Response to pembrolizumab after first-line chemotherapy is vital to prolonged survival in advanced, unresectable, and/or metastatic urothelial carcinoma (aUC). However, there are sparse clinical data on host-tumor immune modification...
10.
Iwamoto T, Torimoto K, Gotoh D, Hori S, Nakai Y, Miyake M, et al.
Low Urin Tract Symptoms . 2021 Nov; 14(2):122-128. PMID: 34796672
Objectives: This study aimed to determine whether Dahl salt-sensitive rats fed a high-salt diet would show features of nocturia due to nocturnal polyuria and to examine the efficacy of choreito...